GSTM1 and thalassemia: This study clearly showed that the current guidelines for thalassemia management may be insufficient to implement recommendations in real life and provides evidence for clinical guidelines to recommend targeting a pretransfusion Hb threshold of 9 g/dL in thalassemia major and 8 g/dL in MDS to reduce transfusion burden.